Xencor
IPODesigning Proteins Delivering Medicines™
Xencor was founded in 1997, is headquartered in Pasadena, United States, lists 201–500 employees, and has $75.1M in recorded funding across 5 rounds.
- Headquarters
- Pasadena, California
- Employees
- 201–500
- Founded
- 1997
- Business Model
- B2B
- Website
- xencor.com
- Total Funding
- $75.1M
- Last Round
- $10.0M Series AJun 2013
- Rounds
- 5
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 2 investors for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company developing XmAb-engineered antibodies and cytokines to treat cancer and autoimmune diseases.
Summary
Xencor is a Biotech company based in Pasadena, United States, founded in 1997. It lists 201–500 employees. It has raised $75.1M in total across 5 rounds, most recently a $10.0M Series A round in Jun 2013. Investors include Moore Capital and Stafford Capital Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Dec 2013
Sign up to see all 6 events
Funding: Venture Round through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xencor"><img src="https://indexed.vc/api/badge/company/xencor" alt="Xencor on Indexed.vc" width="260" height="76" /></a>